Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The combination of dexamethasone and dexmedetomidine is used as an adjuvant to local anesthetics in peripheral nerve blocks and other anesthetic procedures. This combination has been studied for its ability to prolong the duration of analgesia compared to using either agent alone or placebo. ## Mechanism of Action The combination works through complementary mechanisms: Dexamethasone, a potent long-acting corticosteroid, prolongs analgesia through: - Anti-inflammatory effects - Inhibition of prostaglandin formation - Promotion of endorphin release - Vasoconstriction that maintains local anesthetic concentration - Inhibition of potassium channels on nociceptive C-fibers[3][7] Dexmedetomidine, an alpha-2 agonist, enhances analgesia through: - Binding to alpha-2 receptors in the central nervous system - Inhibition of nociceptive transmitter release - Vasoconstriction effects - Inhibition of hyperpolarization-activated cation current (Ih current) - Possible local anesthetic action blocking conduction through C and A-delta fibers[3][4][7] ## Clinical Efficacy Research has shown that the combination of dexamethasone and dexmedetomidine: - Significantly increases the duration of analgesia compared to placebo (mean difference 460 minutes) and dexmedetomidine alone (mean difference 388 minutes)[1][2] - Provides similar duration of analgesia as dexamethasone alone (mean difference 50 minutes)[1][2] - May reduce postoperative opioid consumption[4] - Can reduce the incidence of postoperative nausea and vomiting (PONV) when used intraperitoneally in laparoscopic procedures[5] ## Clinical Applications The combination has been studied in various clinical contexts: - Peripheral nerve blocks (including interscalene, popliteal sciatic, and brachial plexus blocks) - Intercostal nerve blocks for thoracoscopic procedures - Intraperitoneal administration during laparoscopic surgeries ## Safety Considerations While generally considered safe as adjuvants, potential concerns include: - Cardiovascular effects (particularly bradycardia with dexmedetomidine in patients with pre-existing heart disease) - Theoretical concerns about neurotoxicity, though studies have not demonstrated significant issues Based on systematic reviews, it appears reasonable to use dexamethasone as the sole adjunct if the goal is to increase the duration of analgesia, as the combination does not provide significant additional benefit over dexamethasone alone but may increase complexity and cost[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on dexamethasone + dexmedetomidine.